TMB Capital Partners’s Amgen AMGN Stock Holding History

TMB Capital Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,017	Closed	-$358K	–	178
2026 Q1	$358K	Buy	1,017 +52	+5%	+$18.5K	0.12%	130
2025 Q4	$316K	Buy	+965	New	+$306K	0.11%	125

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

TMB Capital Partners's AMGN Position: Q2 2026 in Review

TMB Capital Partners sold out of Amgen (AMGN) in Q2 2026, closing a stake of 1,017 shares — an estimated $358K sold.

TMB Capital Partners first reported a position in AMGN in Q4 2025 and held it in 2 quarters. The position peaked at $358K in Q1 2026. 3,143 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

TMB Capital Partners reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
TMB Capital Partners sold 1,017 Amgen shares in Q2 2026, an estimated $358K.
TMB Capital Partners first reported a position in Amgen in Q4 2025 and held it in 2 quarters.
TMB Capital Partners's Amgen position peaked at $358K in Q1 2026.
3,143 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on TMB Capital Partners's 13F filing for Q2 2026, filed 24 Jul 2026.